FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012636246> ?p ?o ?g. }

• W3012636246 endingPage "609" @default.
• W3012636246 startingPage "595" @default.
• W3012636246 abstract "Abstract Objective Head‐to‐head randomized controlled trials (RCTs) are the gold standard for assessing comparative treatment effects. In the absence of direct comparisons between all possible antiepileptic drugs (AEDs), however, clinical decision‐making in focal (partial onset) epilepsy relies on alternative evidence borne from indirect comparisons including network meta‐analyses (NMAs) and from real‐world evidence (RWE) studies. We review NMAs and observational RWE studies comparing AEDs in the adjunctive setting to compare the robustness of these methods and to formulate recommendations for future evidence development. Methods A literature review identified NMAs and RWE studies comparing AEDs for the adjunctive treatment of focal seizures published between January 2008 and October 2018. NMAs were evaluated for robustness using a framework based on guidelines from the National Institute for Health and Care Excellence Decision Support Unit and the International Society for Pharmacoeconomics and Outcomes Research. RWE studies were evaluated using the GRACE checklist. Results From a total of 1993 records, 11 NMAs and six RWE studies were eligible. Key limitations identified in the NMAs include nonsystematic selection of RCTs, unexplored heterogeneity between included RCTs in terms of study and patient characteristics, and selection of AEDs and AED doses or dosing strategies that are not reflective of clinical practice. The main limitations of RWE studies concern sample size, design, and analysis methods. Approximately 90% of comparisons between individual AEDs were nonsignificant in the NMAs. None of the RWE studies adjusted for baseline differences between comparator groups; therefore, they lack the validity to make comparative conclusions. Significance Current NMAs and RWE studies provide only nominal comparative evidence for AED treatments in focal epilepsy, and should be used with caution for decision‐making due to their methodological limitations. To overcome these hurdles, adherence to methodological guidelines and concerted efforts to collect relevant outcome data in the real world are needed." @default.
• W3012636246 created "2020-03-27" @default.
• W3012636246 creator A5008946687 @default.
• W3012636246 creator A5030901765 @default.
• W3012636246 creator A5043546758 @default.
• W3012636246 creator A5052496041 @default.
• W3012636246 creator A5073703487 @default.
• W3012636246 creator A5079889841 @default.
• W3012636246 creator A5082174312 @default.
• W3012636246 date "2020-03-22" @default.
• W3012636246 modified "2023-10-16" @default.
• W3012636246 title "Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs" @default.
• W3012636246 cites W1513935107 @default.
• W3012636246 cites W1571442295 @default.
• W3012636246 cites W1576891234 @default.
• W3012636246 cites W1773781867 @default.
• W3012636246 cites W1897616064 @default.
• W3012636246 cites W1992033758 @default.
• W3012636246 cites W1994030717 @default.
• W3012636246 cites W1997878281 @default.
• W3012636246 cites W1998741804 @default.
• W3012636246 cites W2001862308 @default.
• W3012636246 cites W2016374115 @default.
• W3012636246 cites W2023155012 @default.
• W3012636246 cites W2055557358 @default.
• W3012636246 cites W2061078339 @default.
• W3012636246 cites W2062716772 @default.
• W3012636246 cites W2064306359 @default.
• W3012636246 cites W2068959287 @default.
• W3012636246 cites W2087419416 @default.
• W3012636246 cites W2089709730 @default.
• W3012636246 cites W2090276138 @default.
• W3012636246 cites W2099498461 @default.
• W3012636246 cites W2107427879 @default.
• W3012636246 cites W2109155466 @default.
• W3012636246 cites W2112789502 @default.
• W3012636246 cites W2117388170 @default.
• W3012636246 cites W2125776201 @default.
• W3012636246 cites W2131801584 @default.
• W3012636246 cites W2135808877 @default.
• W3012636246 cites W2151591903 @default.
• W3012636246 cites W2163886527 @default.
• W3012636246 cites W2329055477 @default.
• W3012636246 cites W2339378953 @default.
• W3012636246 cites W2522740415 @default.
• W3012636246 cites W2549409844 @default.
• W3012636246 cites W2617893633 @default.
• W3012636246 cites W2625094576 @default.
• W3012636246 cites W2735301415 @default.
• W3012636246 cites W2747767288 @default.
• W3012636246 cites W2755504031 @default.
• W3012636246 cites W2759324553 @default.
• W3012636246 cites W2769033134 @default.
• W3012636246 cites W2792950270 @default.
• W3012636246 cites W2806669859 @default.
• W3012636246 cites W2808405323 @default.
• W3012636246 cites W2885699097 @default.
• W3012636246 cites W2891964652 @default.
• W3012636246 cites W2980500136 @default.
• W3012636246 cites W300479524 @default.
• W3012636246 cites W3012636246 @default.
• W3012636246 cites W4230449467 @default.
• W3012636246 cites W4252553827 @default.
• W3012636246 cites W4384106262 @default.
• W3012636246 doi "https://doi.org/10.1111/epi.16476" @default.
• W3012636246 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7216985" @default.
• W3012636246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32201951" @default.
• W3012636246 hasPublicationYear "2020" @default.
• W3012636246 type Work @default.
• W3012636246 sameAs 3012636246 @default.
• W3012636246 citedByCount "13" @default.
• W3012636246 countsByYear W30126362462020 @default.
• W3012636246 countsByYear W30126362462021 @default.
• W3012636246 countsByYear W30126362462022 @default.
• W3012636246 countsByYear W30126362462023 @default.
• W3012636246 crossrefType "journal-article" @default.
• W3012636246 hasAuthorship W3012636246A5008946687 @default.
• W3012636246 hasAuthorship W3012636246A5030901765 @default.
• W3012636246 hasAuthorship W3012636246A5043546758 @default.
• W3012636246 hasAuthorship W3012636246A5052496041 @default.
• W3012636246 hasAuthorship W3012636246A5073703487 @default.
• W3012636246 hasAuthorship W3012636246A5079889841 @default.
• W3012636246 hasAuthorship W3012636246A5082174312 @default.
• W3012636246 hasBestOaLocation W30126362462 @default.
• W3012636246 hasConcept C126322002 @default.
• W3012636246 hasConcept C141071460 @default.
• W3012636246 hasConcept C142724271 @default.
• W3012636246 hasConcept C15744967 @default.
• W3012636246 hasConcept C168563851 @default.
• W3012636246 hasConcept C17744445 @default.
• W3012636246 hasConcept C177713679 @default.
• W3012636246 hasConcept C180747234 @default.
• W3012636246 hasConcept C189708586 @default.
• W3012636246 hasConcept C199539241 @default.
• W3012636246 hasConcept C204787440 @default.
• W3012636246 hasConcept C23131810 @default.
• W3012636246 hasConcept C2776738588 @default.
• W3012636246 hasConcept C2778111679 @default.

• next